Vimian Group AB (publ) (OTCMKTS:VIMGF) Sees Significant Decrease in Short Interest

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 555,800 shares, adeclineof51.4% from the July 15th total of 1,144,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 5,558.0 days. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 5,558.0 days.

Vimian Group AB (publ) Price Performance

Shares of OTCMKTS:VIMGF opened at C$4.30 on Tuesday. The business’s 50-day moving average is C$4.29 and its 200-day moving average is C$4.15. Vimian Group AB has a 1 year low of C$3.15 and a 1 year high of C$4.50.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.